Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-16129 FLUOR CORPORATION (Exact name of registrant as specified in its charter) (State or other jurisdiction of (I.R.S. ...

Condensed Consolidated Interim Financial Statements For the three and nine months ended September 30, 2025 and 2024 (Unaudited, expressed in thousands of United States dollars, unless otherwise stated) TABLE OF CONTENTS | Condensed Consolidated Interim Statements of Financial Position | 2 | | --- | --- | | Condensed Consolidated Interim Statements of Operations and Comprehensive Income (Loss) | 3 | | Condensed Consolidated Interim Statements of Changes in Equity | 4 | | Condensed Consolidated Interim Statem ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 3, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-33076 WILLDAN GROUP, INC. (Exact Name of Registrant as Specified in Its Charter) (IRS Employer Identification No.) Delaw ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2025 Commission File Number 001-18761 MONSTER BEVERAGE CORPORATION (Exact name of registrant as specified in its charter) Delaware 47-1809393 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 1 Monster Way Corona, California 9287 ...

Financial Position - As of September 30, 2025, Eledon Pharmaceuticals reported estimated cash, cash equivalents, and short-term investments of approximately $93.4 million[6] Clinical Trials - The company announced results from its Phase 2 BESTOW trial evaluating tegoprubart for the prevention of organ rejection in kidney transplant patients[9] - A conference call is scheduled for November 7, 2025, to discuss updated Phase 2 BESTOW clinical data[10]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM _____________ TO _____________ Commission File Number: 001-12421 NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) (State or other juris ...

Financial Performance - Revenues for Q3 2025 were $88,906,000, a slight increase of 0.5% compared to $88,479,000 in Q3 2024[15] - Net income for Q3 2025 was $453,000, compared to a net loss of $60,630,000 in Q3 2024, indicating a significant improvement[15] - Total revenues for the nine months ended September 30, 2025, were $264,004, a 1.1% increase from $261,111 in the same period of 2024[144] - The company reported a net loss available to common stockholders of $4,518,000 for Q3 2025, compared to a loss of $65,208,000 in Q3 2024[15] - For the nine months ended September 30, 2025, the net loss was $13,032,000, a significant improvement compared to a net loss of $63,392,000 for the same period in 2024, representing a reduction of approximately 79.5%[19] Revenue Breakdown - Content & Ad Measurement revenue for Q3 2025 was $75,519, representing 84.9% of total revenue, with a slight increase of 0.3% from $75,274 in Q3 2024[143] - Research & Insight Solutions revenue for Q3 2025 was $13,387, a 1.4% increase from $13,205 in Q3 2024[143] - Cross-Platform revenue for the nine months ended September 30, 2025, increased by 32.4% to $34,761 from $26,252 in 2024[144] - Research & Insight Solutions revenue for the nine months ended September 30, 2025, decreased by 6.0% to $38,566 from $41,028 in 2024[144] Expenses and Costs - Cost of revenues for Q3 2025 was $52,783,000, up from $52,005,000 in Q3 2024, representing an increase of 1.5%[15] - Total expenses from operations for Q3 2025 were $87,201,000, down from $148,084,000 in Q3 2024, a decrease of 41.0%[15] - Selling and marketing expenses for Q3 2025 totaled $14,551,000, representing 16.4% of revenue, an increase of 16.3% from $12,515,000 in Q3 2024[151] - Employee costs within selling and marketing increased by 18.2% to $11,451,000 in Q3 2025, primarily due to higher commissions and bonuses[151] - Research and development expenses for Q3 2025 were $7,184,000, accounting for 8.1% of revenue, a slight decrease of 1.2% from $7,272,000 in Q3 2024[154] Assets and Liabilities - Total current assets decreased to $91,518,000 as of September 30, 2025, down from $108,057,000 as of December 31, 2024, a decline of 15.3%[14] - Total liabilities decreased to $225,732,000 as of September 30, 2025, from $231,040,000 as of December 31, 2024, a reduction of 2.3%[14] - The total stockholders' equity (deficit) as of September 30, 2025, was $(26,257,000), compared to $(8,263,000) as of December 31, 2024[14] - The company’s accumulated deficit increased to $1,501,204,000 as of September 30, 2025, compared to $1,474,268,000 as of December 31, 2024[14] Cash Flow and Financing - Net cash provided by operating activities for the nine months ended September 30, 2025, was $19,489,000, down from $28,140,000 in 2024, indicating a decrease of about 30.8%[19] - The company reported a total cash, cash equivalents, and restricted cash of $29,883,000 as of September 30, 2025, up from $20,185,000 in 2024, marking an increase of about 48.4%[19] - The company has agreed to make a one-time cash payment of $2,000,000 to each of the Preferred Stockholders on June 30, 2028, contingent upon the closing of the Exchange Agreements[25] - The company incurred stock-based compensation expense of $2,863,000 for the nine months ended September 30, 2025, an increase from $2,267,000 in 2024, representing a rise of approximately 26.4%[19] Debt and Preferred Stock - The Credit Agreement provides a borrowing capacity of $60 million, consisting of a $45 million term loan and a $15 million revolving credit facility[85] - As of September 30, 2025, accrued dividends for the Preferred Stock totaled $22.9 million, with no shares converted into Common Stock[78] - The company was in compliance with the covenants under the Credit Agreement as of September 30, 2025[91] - The company issued 82,527,609 shares of Preferred Stock on March 10, 2021, generating gross proceeds of $204 million, with net proceeds of $187.9 million after issuance costs[64] Impairment and Goodwill - The company incurred no impairment charges related to goodwill during the three and nine months ended September 30, 2025, following a $63,000,000 charge in the same periods of 2024[159] - The Company recorded a $63.0 million non-cash impairment charge for goodwill during the three and nine months ended September 30, 2024, after concluding that the estimated fair value of its reporting unit was less than its carrying value[42] Legal and Compliance - The Company is involved in various legal proceedings, with a potential sales tax liability assessment from Washington state amounting to approximately $8.0 million[131] - The company conducted an evaluation of its disclosure controls and procedures, concluding they were effective as of September 30, 2025[206] - There were no changes in internal control over financial reporting during the most recent fiscal quarter that materially affected the company's internal control[207]

Financial Performance - Oil and natural gas sales for Q3 2025 were $112.7 million, with net income of $14.5 million, or $0.11 per diluted share, compared to $9.1 million, or $0.07 per diluted share in Q3 2024[5][8] - Adjusted EBITDAX for Q3 2025 totaled $78.6 million, up from $75.4 million in Q3 2024, while cash flow from operating activities was $77.8 million[6][8] - Net income for the nine months ended September 30, 2025, was $49,416,000, compared to $30,381,000 for the same period in 2024, reflecting a growth of 62.7%[33] - The company’s net income for Q3 2025 was $14.523 million, a 60.5% increase from $9.054 million in Q3 2024[44] - Adjusted Net Income for the nine months ended September 30, 2025, was $54,695,000, up from $50,946,000 in the same period of 2024, reflecting a 3.7% growth[50] - Earnings per diluted share for Q3 2025 was $0.11, up from $0.07 in Q3 2024, marking a 57.1% increase[50] - Adjusted Earnings Per Diluted Share for the nine months ended September 30, 2025, was $0.42, compared to $0.39 in 2024, reflecting a 7.7% growth[50] Production and Sales - Daily oil production volumes increased by 28% to 16,222 barrels per day, and natural gas production rose by 25% to 94,217 thousand cubic feet per day[7][8] - Oil and natural gas sales for the three months ended September 30, 2025, were $112,671,000, a 19.8% increase from $94,075,000 in the same period of 2024[31] - Oil sales amounted to $91.960 million in Q3 2025, up 7.4% from $85.503 million in Q3 2024[35] - Natural gas and related product sales surged to $20.711 million, a significant increase of 142.5% compared to $8.572 million in Q3 2024[35] - The company reported a total production of 2,937 MBoe in Q3 2025, an increase of 26.8% from 2,316 MBoe in Q3 2024[35] Expenses and Liabilities - Lease operating expenses were $23.6 million, or $8.03 per barrel of oil equivalent, compared to $13.0 million, or $5.62 per barrel of oil equivalent in the same period last year[10][8] - Operating expenses for Q3 2025 totaled $93.081 million, up from $69.060 million in Q3 2024, indicating a 34.8% increase[35] - Total current liabilities decreased to $76,963,000 as of September 30, 2025, down from $101,808,000 at December 31, 2024, a reduction of approximately 24.4%[29] - Long-term debt increased to $300,000,000 as of September 30, 2025, from $205,000,000 at December 31, 2024, representing a rise of 46.3%[29] Investments and Capital Expenditures - The company invested $64.0 million in development capital expenditures and $16.5 million in acquisition capital, closing 17 acquisitions in the Permian and Utica Basins[11][8] - Capital expenditures for oil and natural gas properties amounted to $233,135,000 for the nine months ended September 30, 2025, compared to $193,376,000 in 2024, indicating an increase of 20.6%[33] - The company has provided 2025 guidance for annual production between 31,000 and 33,000 barrels of oil equivalent per day, with total capital expenditures expected to be between $400 million and $420 million[17][8] Shareholder Returns - The company declared a quarterly dividend of $0.11 per share, payable on December 15, 2025[8][4] Other Financial Metrics - The gain on derivatives for the three months ended September 30, 2025, was $5,224,000, compared to $11,841,000 in the same period of 2024, a decrease of 55.8%[31] - The company reported a net cash provided by operating activities of $231,914,000 for the nine months ended September 30, 2025, compared to $207,536,000 in 2024, an increase of 11.7%[33] - The company’s net debt as of September 30, 2025, was $288.168 million, with a net debt to trailing twelve months Adjusted EBITDAX ratio of 0.9[46][47] - The total working capital changes for Q3 2025 resulted in a decrease of $4,663,000, compared to a decrease of $3,987,000 in Q3 2024[53] - The company incurred nonrecurring general and administrative expenses of $1,757,000 related to severance costs in the nine months ended September 30, 2025[50] - The tax impact on adjustments for the nine months ended September 30, 2025, was a negative $1,542,000, compared to a negative $6,143,000 in 2024[50]

Financial Performance - Q3 2025 revenues increased by 2.9% to $363.7 million compared to $353.6 million in Q3 2024[6] - Income from operations rose 197.0% to $28.4 million, significantly improving from a loss of $(29.3) million in Q3 2024[6] - Net loss decreased to $(3.6) million from $(48.6) million in Q3 2024, marking a 92.6% improvement[6] - Adjusted EBITDA for Q3 2025 was $124.1 million, slightly down by 0.5% from $124.7 million in Q3 2024[6] - Adjusted net income for the quarter was $71.5 million, a decrease of 0.8% compared to $72.1 million in Q3 2024[6] - Free cash flow increased by 35.0% to $108.2 million from $80.1 million in Q3 2024[6] - Total revenues for the three months ended September 30, 2025, were $363.711 million, an increase from $353.580 million in the same period of 2024, representing a growth of 3.2%[18] - Net income for the nine months ended September 30, 2025, was $46.984 million, compared to a net loss of $1.040 million in the same period of 2024[20] Cost Management - Operating costs and expenses for the three months ended September 30, 2025, totaled $335.283 million, a decrease from $382.884 million in the same period of 2024, reflecting a reduction of 12.4%[18] - The company incurred a goodwill impairment of $17.579 million for the three months ended September 30, 2025, compared to $85.273 million in the same period of 2024[18] - Share-based compensation for the three months ended September 30, 2025, amounted to $12,197 thousand, compared to $10,161 thousand in the same period of 2024[31] - Sales and marketing expenses decreased to $(133,762) from $(127,418) year-over-year, indicating a focus on cost management[39][42] - Research, development, and engineering costs were reduced to $(14,077) from $(15,255), reflecting efficiency improvements[39][42] - General, administrative, and other related costs decreased to $(38,733) from $(52,417), showcasing effective expense control measures[39][42] - Depreciation and amortization expenses were reported at $(26,124), down from $(51,351) in the prior year, indicating a reduction in asset-related costs[39][42] Guidance and Projections - The company reaffirmed its 2025 revenue guidance range of $1,442 million to $1,502 million[8] - Adjusted EBITDA guidance for 2025 is set between $505 million and $542 million[8] - Adjusted diluted EPS is projected to be between $6.64 and $7.28 for 2025[8] Cash Flow and Investments - Cash flows from operating activities for the nine months ended September 30, 2025, were $215.986 million, slightly down from $232.082 million in the same period of 2024[20] - Total cash and cash equivalents at the end of the period were $503.368 million, down from $386.122 million at the end of September 2024[20] - The company spent $85.888 million on property and equipment purchases in the nine months ended September 30, 2025, compared to $79.476 million in the same period of 2024[20] - Free cash flow for the year-to-date 2025 was $130,098, with net cash provided by operating activities totaling $215,986[50] Adjustments and Non-GAAP Measures - The adjusted effective tax rate is calculated based on the GAAP effective tax rate with adjustments for non-GAAP adjustments to net income[29] - For the three months ended September 30, 2025, the adjusted net income was $71,470, with an adjusted effective tax rate of approximately 25.2%[39] - Total non-GAAP adjustments for the quarter amounted to $24,015, indicating significant adjustments made to reconcile GAAP to non-GAAP financial measures[39][42] - For the nine months ended September 30, 2025, the adjusted net income was $172,042, with an adjusted effective tax rate of approximately 24.6%[44] - The total non-GAAP adjustments for the same period amounted to $69,066 in share-based compensation and $27,292 in transaction and integration charges[44] Investment and Credit Management - The company reported a provision for credit losses on investments of $17.566 million for the nine months ended September 30, 2025, compared to no provision in the same period of 2024[20] - The company reported a provision for credit losses on investments of $(17,566), reflecting a cautious approach to credit risk management[39][42]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________ FORM 10-Q ____________________ (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation or Organization) Delaware 06-1500476 (I.R.S. Employer Identification No.) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCH ...